StockData
Surrozen, Inc./DE logo

Surrozen, Inc./DE (SRZN) stock

SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$31.61−0.06 (-0.19%)

Close on Nov 13, 2026Market cap $371.53MP/E –Yield –

Surrozen profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Surrozen's profit margin for the twelve months ending Jun 30, 2026 was -2885.3%. For fiscal 2025 it was -6960.8%, against -596.6% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-6960.8%−6364.2
FY2024Dec 31, 2024-596.6%−308.5
FY2022Dec 31, 2022-288.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20261003.5%−3039.8
Q1 FY2026Mar 31, 2026-2550.1%+193.5
Q4 FY2025Dec 31, 2025-34689.2%−30408.4
Q3 FY2025Sep 30, 2025-7288.2%−7273.9
Q2 FY2025Jun 30, 20254043.3%–
Q1 FY2025Mar 31, 2025-2743.6%–
Q4 FY2024Dec 31, 2024-4280.8%–
Q3 FY2024Sep 30, 2024-14.3%–

More Surrozen figures

See a number that looks wrong?